CEL Celadon Pharmaceuticals Plc

61.00

1.50 (2.52%)

22 Jul 2024 - Closed

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Celadon Pharmaceuticals Plc	LSE:CEL	London	Ordinary Share	GB00BDQYGP38	ORD 1P

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	1.50	2.52%	61.00	57.00	65.00	61.00	59.50	59.50	12,246	14:00:11

Industry Sector	Turnover	Profit	EPS - Basic	PE Ratio	Market Cap
Investment Advice	149k	-7.14M	-0.1082	-5.64	39.26M

Directors' Shareholdings

31/08/2004 8:00am

UK Regulatory

RNS Number:4095C
Celsis International PLC
31 August 2004



                            CELSIS INTERNATIONAL PLC

                            Directors' Shareholdings



Celsis International plc ("the Company") was notified on 30 August 2004 that on
    27 August 2004 Jay LeCoque, Chief Executive Officer and Christian Madrolle,
Finance Director, have each re-invested dividends they received from the Company
in Celsis International plc shares.



Mr LeCoque has acquired 8,000 Celsis ordinary 1p shares, at 31p, making his
total holding 558,000 shares representing 0.5% of the issued share capital.  Mr
Madrolle has purchased 6,000 Celsis ordinary 1p shares, also at 31p, with his
holding totalling 406,000 shares representing 0.36% of the issued share capital.



                                                                  31 August 2004


Enquiries:

Celsis International plc                              Tel: 01638 600 151
Jenny Parsons, Corporate Communications

College Hill                                          Tel: 020 7457 2020
Corinna Dorward




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

RDSILFITTIIDFIS